Clinical Trial Update: Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluated the efficacy and safety of insulin aspart in children under 7 years with Type 1 diabetes. The study, sponsored by Novo Nordisk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (NovoLog) (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED